We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

NGM Biopharmaceuticals Inc (NGM) USD0.001

Sell:$1.48 Buy:$1.68 Change: $0.03 (1.85%)
NASDAQ:0.12%
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Takeover

NGM Biopharmaceuticals Inc USD0.001

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 21 Mar 2024)

Atlas Neon Parent Inc and Atlas Neon Merger Sub Inc (affiliates of The Column Group LP) have made an offer to buy NGM Biopharmaceuticals Inc shares at a price of USD1.55 per share. The company have now launched an election facility where shareholders have the option to accept this offer.

 

If you don’t want to sell any shares, you don’t need to do anything. Depending on the level of acceptance the offeror may choose to delist or compulsorily acquire the remaining shares at a later date.

 

Accept the offer – Act by noon on Thursday 28 March 2024

 

Cash from any successful tender will be converted to Pound Sterling upon receipt, based on the prevailing exchange rate at the time and our standard currency conversion fees and credited to your account.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter/message and not on the summary information outlined above.

×
Sell:$1.48
Buy:$1.68
Change: $0.03 (1.85%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Takeover

NGM Biopharmaceuticals Inc USD0.001

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 21 Mar 2024)

Atlas Neon Parent Inc and Atlas Neon Merger Sub Inc (affiliates of The Column Group LP) have made an offer to buy NGM Biopharmaceuticals Inc shares at a price of USD1.55 per share. The company have now launched an election facility where shareholders have the option to accept this offer.

 

If you don’t want to sell any shares, you don’t need to do anything. Depending on the level of acceptance the offeror may choose to delist or compulsorily acquire the remaining shares at a later date.

 

Accept the offer – Act by noon on Thursday 28 March 2024

 

Cash from any successful tender will be converted to Pound Sterling upon receipt, based on the prevailing exchange rate at the time and our standard currency conversion fees and credited to your account.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter/message and not on the summary information outlined above.

×
Sell:$1.48
Buy:$1.68
Change: $0.03 (1.85%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Takeover

NGM Biopharmaceuticals Inc USD0.001

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 21 Mar 2024)

Atlas Neon Parent Inc and Atlas Neon Merger Sub Inc (affiliates of The Column Group LP) have made an offer to buy NGM Biopharmaceuticals Inc shares at a price of USD1.55 per share. The company have now launched an election facility where shareholders have the option to accept this offer.

 

If you don’t want to sell any shares, you don’t need to do anything. Depending on the level of acceptance the offeror may choose to delist or compulsorily acquire the remaining shares at a later date.

 

Accept the offer – Act by noon on Thursday 28 March 2024

 

Cash from any successful tender will be converted to Pound Sterling upon receipt, based on the prevailing exchange rate at the time and our standard currency conversion fees and credited to your account.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter/message and not on the summary information outlined above.

×
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Share news, reports & tips

No news items about NGM Biopharmaceuticals Inc USD0.001 were found.

Company announcements Announcements

No company announcements about NGM Biopharmaceuticals Inc USD0.001 were found.


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.

© Digital Look Ltd 1998-2024. All rights reserved.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.